HONG KONG, March 25, 2026 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (NASDAQ:IMG), a business group specializing in digital health and sales development, which utilizes technologies and marketing networks to enhance its business partners' sales growth and commercial value, today announced that it has reported its financial results for the three months ended December 31, 2025, which shows that the Company achieved significant revenue growth and a continued reduction in net loss for such period.

Financial Results for the Three Months ended December 31, 2025 (vs. the same period in 2024)

1. Total revenue was $15,768,796 during the three months ended December 31, 2025, compared to $22,853 in the prior-year period, reflecting the initial impact of the Company's expansion into medicine-food homology products and computing power solutions. This growth primarily reflects early-stage commercialization and expansion of new business lines.

2. Expanded scale of digital asset holdings: As of December 31, 2025, the Company held 730 Bitcoins with a carrying value of $63,978,821.

3. As of December 31, 2025, the book value per share was approximately $3.6, based on the number of the Company's shares outstanding as of that date.

Progress in Business Strategic Transformation and Operations

During the three months ended December 31, 2025, the Company continued to advance its transformation to the health consumer goods category and computing power technology products in the Asia market, with multiple key progress made:

1. Continuous improvement of product line layout: Relying on digital marketing strategies, the Company achieved sales growth of its medicine-food homology products; the computing power product series was officially launched in September 2025, providing enterprise customers with GPU hardware devices integrated with artificial intelligence data ...